Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-04-30NCT04546620

2 results · Page 1 of 1

Swipe the table sideways for more columns.

33 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's HospitalCambridgeUnited Kingdom26
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom18
Chase Farm and Barnet HospitalsLondonUnited Kingdom1
Churchill HospitalOxfordUnited Kingdom17
Colchester General HospitalColchesterUnited Kingdom1
Derriford HospitalPlymouthUnited Kingdom27
East Kent Hospitals NHS Foundation TrustCanterburyUnited Kingdom1
Freeman HospitalNewcastleUnited Kingdom14
Ipswich HospitalIpswichUnited Kingdom8
Leicester Royal InfirmaryLeicesterUnited Kingdom19
Lewisham and Greenwich NHS TrustLondonUnited Kingdom1
Maidstone HospitalMaidstoneUnited Kingdom8
Milton Keynes University HospitalMilton KeynesUnited Kingdom6
Monklands HospitalAirdrieUnited Kingdom2
Norfolk and Norwich University HospitalNorwichUnited Kingdom11
Nottingham City HospitalNottinghamUnited Kingdom19
Queen Alexandra HospitalPortsmouthUnited Kingdom13
Queen's HospitalRomfordUnited Kingdom4
Queens HospitalBurton-on-TrentUnited Kingdom1
Royal Cornwall HospitalTruroUnited Kingdom15
Royal Derby HospitalDerbyUnited Kingdom14
Royal Devon and Exeter HospitalExeterUnited Kingdom12
Royal Oldham HospitalOldhamUnited Kingdom3
Royal Stoke University HospitalStoke-on-TrentUnited Kingdom10
Singleton HospitalSwanseaUnited Kingdom7